All Names: Evenity
Indications:Postmenopausal Women with Osteoporosis at High Risk for Fracture
Manufacturer:Amgen,USA
Customs Clearance Procedure:If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
INDICATIONS AND USAGE(适应症)
Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
EVENITY is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
DOSAGE(服用剂量)
Two separate syringes (and two separate subcutaneous injections) are needed to administer the total dose of 210 mg of EVENITY. Inject two 105 mg/1.17 mL prefilled syringes, one after the other.
EVENITY should be administered by a healthcare provider.
Recommended Dosage
The recommended dose of EVENITY is 210 mg administered subcutaneously in the abdomen, thigh or upper arm. Administer EVENITY once every month.
The treatment duration for EVENITY is 12 monthly doses.
Patients should be adequately supplemented with calcium and vitamin D during treatment with EVENITY.
If the EVENITY dose is missed, administer as soon as it can be rescheduled. Thereafter, EVENITY can be scheduled every month from the date of the last dose.
ADVERSE REACTIONS(不良反应)
Major adverse cardiac events
Hypersensitivity
Hypocalcemia
Osteonecrosis of the Jaw
Atypical Subtrochanteric and Diaphyseal Femoral Fractures
For full information, please refer to:
https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/471baba2-7154-4488-9891-0db2f46791e7/spl-doc?hl=evenity
Evenityinformation
No information yet!!!